Access Program Information
Establish the efficacy of initial high frequency loading of intravitreal pegaptanib
bi-weekly during the initial treatment period when the VEGF levels are the greatest and then
gradually extending the administration frequency to monthly as homeostasis ensues for the
treatment of DME, as measured by best-corrected visual acuity.